You are here: Home: BCU Surgeons 2005 Vol 4 Issue 2 : Editor's office
| |
|
|
| |
EDITOR
Neil Love, MD
ASSOCIATE EDITORS
Michelle Paley, MD
Richard Kaderman, PhD
WRITERS
Lilliam Sklaver Poltorack
PharmD
Sally Bogert, RNC, WHCNP
Douglas Paley
Kathryn Ault Ziel, PhD
CME DIRECTOR
Michelle Paley, MD
CONTENT VALIDATION
Margaret Peng
ART DIRECTOR
Tamara Dabney
SENIOR DESIGNER
Christina Brigham
GRAPHIC DESIGNERS
Ben Belin
Maria Schaefer
Jason Cunnius
PRODUCTION EDITOR
Aura Herrmann
|
ASSOCIATE PRODUCTION
EDITOR
Alexis Oneca
COPY EDITORS
Sandy Allen
Joy Davis
Pat Morrissey/Havlin
Susan Petrone
AUDIO PRODUCTION
Frank Cesarano
TECHNICAL SERVICES
Arly Ledezma
WEB DESIGN
John Ribeiro
PRODUCTION MANAGER
Patricia Kappes
EDITORIAL ASSISTANTS
Patricia McWhorter
Raquel Segura
Tere Sosa
Ginelle Suarez
Arlene Thorstensen |
CONTACT INFORMATION:
Neil Love, MD
RESEARCH TO PRACTICE
One Biscayne Tower
2 South Biscayne Boulevard
Suite 3600
Miami, FL 33131
Fax: (305) 377-9998
Email: NLove@ResearchToPractice.net
FOR CME INFORMATION:
Melissa Vives,
Associate CME Administrator
Email: MVives@ResearchToPractice.net
|
This program is supported by education grants from AstraZeneca Pharmaceuticals LP and Genomic Health Inc.
The audio tapes, compact discs, Internet content and accompanying printed material are protected by copyright. No part of this program may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or utilizing any information storage and retrieval system, without written permission from the copyright owner.
The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.
Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information and comparison with recommendations of other authorities.
|
|
| |
|
|
| |
|
|
|
|
|
